PDGF in bone formation and regeneration: New insights into a novel mechanism involving MSCs
Open accessAbstract
With the identification of mesenchymal stem cells (MSCs) as pericytes, the details of bone formation, regeneration, and repair take on new meaning. Growth factors and other signaling molecules together with MSCs play important roles in these bone fabrication processes. However, the interaction of these cellular healing components is not completely understood. The formation of new vasculature is critical to regeneration and repair as both the driver and orientor of new bone formation. In this context, MSCs are proposed to be largely derived from pericytes associated with the vasculature. A comprehensive perspective is presented in which signaling molecules such as PDGF take on new significance in the vasculature-pericyte-MSC-osteoblast dynamics. Current data suggest that PDGF could function as a central connector between the cellular components and contributors of the osteoblast differentiation program. The inference is that PDGF could function at sites of injury to mobilize the pericytes from their abluminal location, stimulate mitotic expansion of these cells and help organize them. In this way, PDGF both contributes to the osteogenic lineage and helps to stabilize newly forming vessels that act to drive the multistep, multicomponent cascade of new bone formation. This thesis explains how PDGF functions as a powerful therapeutic agent for bone formation and repair.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MSC response to inflammatory factors released from the bone fracture site, such as PDGFs and BMPs, activates BMP-Smad1/5/8 signaling, promoting MSC migration.
“This process is triggered by the response of MSCs to inflammatory factors released from the bone fracture site, such as PDGFs and BMPs, which activate BMP-Smad1/5/8 signaling, promoting MSC migration [40,77,78].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [77]
PDGF-BB attracts pericytes, contributing to vascular stability, and promotes the differentiation of MSCs into osteoblastic progenitors during active angiogenesis.
“PDGF-BB attracts pericytes, contributing to vascular stability, and has implications for fracture repair by promoting the differentiation of MSCs into osteoblastic progenitors during active angiogenesis [39,77].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [77]
HIF-1α upregulates SDF-1 production in damaged bone cells, facilitating MSC migration to the defect site and enhancing bone regeneration.
“Additionally, hypoxia-inducible factor 1-α (HIF-1α) upregulates stromal cell-derived factor-1 (SDF-1) production in damaged bone cells, facilitating MSC migration to the defect site and enhancing bone regeneration [40,77].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [77]
Cites
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · see citing works
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048 · see citing works
Chemotaxis of human articular chondrocytes and mesenchymal stem cells
Mishima, Y., & Lotz, M. (2008) · Journal of Orthopaedic Research · doi:10.1002/jor.20668 · Cited by 192 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis
Xie, H., Cui, Z., Wang, L., Xia, Z., Hu, Y., Xian, L., Li, C., Xie, L., Crane, J., Wan, M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3668 · Cited by 951 · see citing works
Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects
Perez, J. R., Kouroupis, D., Li, D. J., Best, T. M., Kaplan, L., & Correa, D. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00105 · Cited by 390 · see citing works
Self-citationMesenchymal stem cells: Amazing remedies for bone and cartilage defects
Kangari, P., Talaei-Khozani, T., Razeghian-Jahromi, I., & Razmkhah, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02001-1 · Cited by 286 · see citing works
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
Kong, D.-H., Kim, M., Jang, J., Na, H.-J., & Lee, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081786 · Cited by 161 · see citing works
Baron, M., Drohat, P., Crawford, B., Hornicek, F. J., Best, T. M., & Kouroupis, D. (2023) · Bioengineering · doi:10.3390/bioengineering10101187 · Cited by 19 · see citing works
Yi, H., Wang, Y., Liang, Q., & Mao, X. (2022) · Cell Transplantation · doi:10.1177/09636897211051743 · Cited by 18 · see citing works
- Authors
- Caplan, A. I., & Correa, D.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Caplan, Arnold I.
- Venue
- Journal of Orthopaedic Research
- Publisher
- Wiley
- Published
- 2011-05-25
- Volume
- 29
- Issue
- 12
- Pages
- 1795-1803
- ISSN
- 0736-0266 (ISSN-L)
- 1554-527X
- OpenAlex
- W2033419489
- Cited by
- 312
- References
- 3
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 13 · 2023: 16 · 2022: 26 · 2021: 27 · 2020: 27 · 2019: 20 · 2018: 21 · 2017: 23 · 2016: 24 · 2015: 21 · 2014: 25 · 2013: 23 · 2012: 25
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Orthopaedic Research® (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AR053622)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR053622, P01AR053622)
- Armed Forces Institute of Regenerative Medicine
- Topics
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Keywords
- platelet-derived growth factor, bone formation, bone regeneration, mesenchymal stem cells, pericytes, osteogenic differentiation, angiogenesis, growth factor signaling
- MeSH terms
- Becaplermin, Blood Platelets, Bone Development, Cell Communication, Humans, Osteogenesis, Platelet-Derived Growth Factor, Regeneration, Pericytes, Proto-Oncogene Proteins c-sis, Fractures, Bone, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review